Anti-SARS-CoV-2 Spike RBD antibody [T5P8-F9] - BSA and Azide free
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(0 Publication)
Llama Recombinant Monoclonal SPIKE antibody. Carrier free. Suitable for ELISA and reacts with SARS-CoV-2 samples.
View Alternative Names
2, S, Spike glycoprotein, S glycoprotein, E2, Peplomer protein
- ELISA
Supplier Data
ELISA - Anti-SARS-CoV-2 Spike RBD antibody [T5P8-F9] - BSA and Azide free (AB288141)
Direct ELISA using SARS-CoV2 Spike RBD recombinant protein (aa 319-541) and SARS-CoV2 Spike S1 RBD recombinant protein (aa 16-685) as coating antigen at 1 μg/mL. ab288141 was used as detection antibody, followed by an anti-c-Myc antibody at at 1 μg/mL.
Secondary antibody is a Goat anti-Mouse IgG-HRP conjugate at 1/5000 dilution.
ab288141 can detect SARS-CoV2 Spike RBD at 10 ng/mL and can weakly detect SARS-CoV2 Spike S1 at 200 ng/mL..
Reactivity data
Product details
Antibody is supplied as a His-tagged purified protein. It also contains a myc-tag for detection.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The SARS-CoV-2 Spike RBD interacts directly with the host ACE2 receptor to mediate entry of the virus into host cells. This interaction is necessary for the virus to fuse with the host cell membrane which allows viral RNA to enter the host cell and begin replication. The Spike protein of which the RBD is a part forms a trimeric complex on the virus surface that is important for host interaction. Variations in the Spike RBD such as mutations like Arg319-Phe541 have significant impacts on the binding affinity to ACE2 and the effectiveness of vaccine-elicited antibodies.
Pathways
The Spike RBD of SARS-CoV-2 is vital in the entry pathway of the virus into the host cell. It is prominently involved in the ACE2-mediated signaling pathway with ACE2 playing the key role as the cellular receptor. This pathway is integral to the pathogenesis of COVID-19. Additionally the presence of the virus in host cells can trigger inflammatory pathways via infection-induced signaling cascades which can lead to exacerbated immune responses.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Additional targets
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com